Guidelines for Colonoscopy Surveillance After Cancer Resection: A Consensus Update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer

Gastroenterology

Volumn 130, Issue 6, 2006, Pages 1865-1871

  Rex, Douglas K ^a   Kahi, Charles J ^a   Levin, Bernard ^b   Smith, Robert A ^c   Bond, John H ^d   Brooks, Durado ^c   Burt, Randall W ^e   Byers, Tim ^f   Fletcher, Robert H ^g   Hyman, Neil ^h   Johnson, David ⁱ   Kirk, Lynne ^k   Lieberman, David A ^j   Levin, Theodore R ^l   O'Brien, Michael J ^m   Simmang, Clifford ^k   Thorson, Alan G ⁿ   Winawer, Sidney J ^o  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c AMERICAN CANCER SOCIETY   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e UNIVERSITY OF UTAH   (United States)

^f UNIVERSITY OF COLORADO   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF VERMONT   (United States)

ⁱ Eastern Virginia School of Medicine   (United States)

^j OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^k UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^l KAISER PERMANENTE MEDICAL CENTER   (United States)

^m BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ CREIGHTON UNIVERSITY   (United States)

^o MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ARTICLE; BARIUM ENEMA; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; COLON; COLONOSCOPY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; FAMILY HISTORY; HUMAN; LIVER METASTASIS; LUNG METASTASIS; NON PROFIT ORGANIZATION; PERIOPERATIVE PERIOD; POLYPECTOMY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECTUM CANCER; SIGMOIDOSCOPY; TREATMENT OUTCOME; UNITED STATES;

EID: 33646350740     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.03.013     Document Type: Article

References (66)

1. Winawer S.J., Zauber A.G., Fletcher R.H., Stillman J.S., O'Brien M.J., Levin B., Smith R.A., Lieberman D.A., Burt R.W., Levin T.R., Bond J.H., Brooks D., Byers T., Hyman N., Kirk L., Thorson A., Simmang C., Johnson D., and Rex D.K. Guidelines for Colonoscopy Surveillance After Polypectomy. a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology 130 (2006) 1872-1885
2. Barillari P., Ramacciato G., Manetti G., Bovino A., Sammartino P., and Stipa V. Surveillance of colorectal cancer. effectiveness of early detection of intraluminal recurrences on prognosis and survival of patients treated for cure. Dis Colon Rectum 39 (1996) 388-393
3. Barrier A., Houry S., and Huguier M. The appropriate use of colonoscopy in the curative management of colorectal cancer. Int J Colorectal Dis 13 (1998) 93-98
4. Carlsson G., Petrelli N.J., Nava H., Herrera L., and Mittelman A. The value of colonoscopic surveillance after curative resection for colorectal cancer or synchronous adenomatous polyps. Arch Surg 122 (1987) 1261-1263
5. Castells A., Bessa X., Daniels M., Ascaso C., Lacy A.M., Garcia-Valdecasas J.C., Gargallo L., Novell F., Astudillo E., Filella X., and Pique J.M. Value of postoperative surveillance after radical surgery for colorectal cancer. results of a cohort study. Dis Colon Rectum 41 (1998) 714-724
6. Chen F., and Stuart M. Colonoscopic follow-up of colorectal carcinoma. Dis Colon Rectum 37 (1994) 568-572
7. Eckardt V.F., Stamm H., Kanzler G., and Bernhard G. Improved survival after colorectal cancer in patients complying with a postoperative endoscopic surveillance program. Endoscopy 26 (1994) 523-527
8. Granqvist S., and Karlsson T. Postoperative follow-up of patients with colorectal carcinoma by colonoscopy. Eur J Surg 158 (1992) 307-312
9. Green R.J., Metlay J.P., Propert K., Catalano P.J., Macdonald J.S., Mayer R.J., and Haller D.G. Surveillance for second primary colorectal cancer after adjuvant chemotherapy. an analysis of Intergroup 0089. Ann Intern Med 136 (2002) 261-269
10. Juhl G., Larson G.M., Mullins R., Bond S., and Polk Jr. H.C. Six-year results of annual colonoscopy after resection of colorectal cancer. World J Surg 14 (1990) 255-261
11. Khoury D.A., Opelka F.G., Beck D.E., Hicks T.C., Timmcke A.E., and Gathright Jr. J.B. Colon surveillance after colorectal cancer surgery. Dis Colon Rectum 39 (1996) 252-256
12. Kjeldsen B.J., Kronborg O., Fenger C., and Jorgensen O.D. A prospective randomized study of follow-up after radical surgery for colorectal cancer. Br J Surg 84 (1997) 666-669
13. Kronborg O., Hage E., and Deichgraeber E. The remaining colon after radical surgery for colorectal cancer. The first three years of a prospective study. Dis Colon Rectum 26 (1983) 172-176
14. Makela J.T., Laitinen S.O., and Kairaluoma M.I. Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg 130 (1995) 1062-1067
15. McFarland R.J., Becciolini C., and Lallemand R.C. The value of colonoscopic surveillance following a diagnosis of colorectal cancer or adenomatous polyp. Eur J Surg Oncol 17 (1991) 514-518
16. Obrand D.I., and Gordon P.H. Incidence and patterns of recurrence following curative resection for colorectal carcinoma. Dis Colon Rectum 40 (1997) 15-24
17. Ohlsson B., Breland U., Ekberg H., Graffner H., and Tranberg K.G. Follow-up after curative surgery for colorectal carcinoma. Randomized comparison with no follow-up. Dis Colon Rectum 38 (1995) 619-626
18. Patchett S.E., Mulcahy H.E., and O'Donoghue D.P. Colonoscopic surveillance after curative resection for colorectal cancer. Br J Surg 80 (1993) 1330-1332
19. Pietra N., Sarli L., Costi R., Ouchemi C., Grattarola M., and Peracchia A. Role of follow-up in management of local recurrences of colorectal cancer. a prospective, randomized study. Dis Colon Rectum 41 (1998) 1127-1133
20. Schoemaker D., Black R., Giles L., and Toouli J. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology 114 (1998) 7-14
21. Skaife P., Seow-Choen F., Eu K.W., and Tang C.L. A novel indicator for surveillance colonoscopy following colorectal cancer resection. Colorectal Dis 5 (2003) 45-48
22. Stigliano V., Fracasso P., Grassi A., Lapenta R., Citarda F., Tomaselli G., Giannarelli D., and Casale V. Endoscopic follow-up in resected colorectal cancer patients. J Exp Clin Cancer Res 19 (2000) 145-148
23. Togashi K., Konishi F., Ozawa A., Sato T., Shito K., Kashiwagi H., Okada M., and Nagai H. Predictive factors for detecting colorectal carcinomas in surveillance colonoscopy after colorectal cancer surgery. Dis Colon Rectum 43 (2000) S47-S53
24. Weber C.A., Deveney K.E., Pellegrini C.A., and Way L.W. Routine colonoscopy in the management of colorectal carcinoma. Am J Surg 152 (1986) 87-92
25. Benson III A.B., Desch C.E., Flynn P.J., Krause C., Loprinzi C.L., Minsky B.D., Petrelli N.J., Pfister D.G., Smith T.J., and Somerfield M.R. 2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines. J Clin Oncol 18 (2000) 3586-3588
26. Renehan A.G., Egger M., Saunders M.P., and O'Dwyer S.T. Impact on survival of intensive follow up after curative resection for colorectal cancer. systematic review and meta-analysis of randomised trials. Br Med J 324 (2002) 813
27. Jeffery G.M., Hickey B.E., and Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev (2002) CD002200
28. Holm T., Johansson H., Cedermark B., Ekelund G., and Rutqvist L.E. Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy. Br J Surg 84 (1997) 657-663
29. Porter G.A., Soskolne C.L., Yakimets W.W., and Newman S.C. Surgeon-related factors and outcome in rectal cancer. Ann Surg 227 (1998) 157-167
30. McArdle C.S., and Hole D. Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival. Br Med J 302 (1991) 1501-1505
31. Steele R.J. The influence of surgeon case volume on outcome in site-specific cancer surgery. Eur J Surg Oncol 22 (1996) 211-213
32. Harmon J.W., Tang D.G., Gordon T.A., Bowman H.M., Choti M.A., Kaufman H.S., Bender J.S., Duncan M.D., Magnuson T.H., Lillemoe K.D., and Cameron J.L. Hospital volume can serve as a surrogate for surgeon volume for achieving excellent outcomes in colorectal resection. Ann Surg 230 (1999) 404-413
33. Panageas K.S., Schrag D., Riedel E., Bach P.B., and Begg C.B. The effect of clustering of outcomes on the association of procedure volume and surgical outcomes. Ann Intern Med 139 (2003) 658-665
34. Kapiteijn E., Marijnen C.A., Nagtegaal I.D., Putter H., Steup W.H., Wiggers T., Rutten H.J., Pahlman L., Glimelius B., van Krieken J.H., Leer J.W., and van de Velde C.J. Dutch Colorectal Cancer G Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345 (2001) 638-646
35. Heald R.J., Husband E.M., and Ryall R.D. The mesorectum in rectal cancer surgery-the clue to pelvic recurrence?. Br J Surg 69 (1982) 613-616
36. Cawthorn S.J., Parums D.V., Gibbs N.M., A'Hern R.P., Caffarey S.M., Broughton C.I., and Marks C.G. Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer. Lancet 335 (1990) 1055-1059
37. Fleshman J.W., Wexner S.D., Anvari M., LaTulippe J.F., Birnbaum E.H., Kodner I.J., Read T.E., Nogueras J.J., and Weiss E.G. Laparoscopic vs. open abdominoperineal resection for cancer. Dis Colon Rectum 42 (1999) 930-939
38. Kwok S.P., Lau W.Y., Carey P.D., Kelly S.B., Leung K.L., and Li A.K. Prospective evaluation of laparoscopic-assisted large bowel excision for cancer. Ann Surg 223 (1996) 170-176
39. Leung K.L., Kwok S.P., Lam S.C., Lee J.F., Yiu R.Y., Ng S.S., Lai P.B., and Lau W.Y. Laparoscopic resection of rectosigmoid carcinoma. prospective randomised trial. Lancet 363 (2004) 1187-1192
40. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project, Martling A.L., Holm T., Rutqvist L.E., Moran B.J., Heald R.J., and Cedemark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Lancet 356 (2000) 93-96
41. Maurer C.A., Z'Graggen K., Renzulli P., Schilling M.K., Netzer P., and Buchler M.W. Total mesorectal excision preserves male genital function compared with conventional rectal cancer surgery. Br J Surg 88 (2001) 1501-1505
42. Fleshman J.W., Myerson R.J., Fry R.D., and Kodner I.J. Accuracy of transrectal ultrasound in predicting pathologic stage of rectal cancer before and after preoperative radiation therapy. Dis Colon Rectum 35 (1992) 823-829
43. Gualdi G.F., Casciani E., Guadalaxara A., d'Orta C., Polettini E., and Pappalardo G. Local staging of rectal cancer with transrectal ultrasound and endorectal magnetic resonance imaging. comparison with histologic findings. Dis Colon Rectum 43 (2000) 338-345
44. Hunerbein M., Pegios W., Rau B., Vogl T.J., Felix R., and Schlag P.M. Prospective comparison of endorectal ultrasound, three-dimensional endorectal ultrasound, and endorectal MRI in the preoperative evaluation of rectal tumors. Preliminary results. Surg Endosc 14 (2000) 1005-1009
45. Mathur P., Smith J.J., Ramsey C., Owen M., Thorpe A., Karim S., Burke C., Ramesh S., and Dawson P.M. Comparison of CT and MRI in the pre-operative staging of rectal adenocarcinoma and prediction of circumferential resection margin involvement by MRI. Colorectal Dis 5 (2003) 396-401
46. Beets-Tan R.G. MRI in rectal cancer. the T stage and circumferential resection margin. Colorectal Dis 5 (2003) 392-395
47. Radcliffe A., and Brown G. Will MRI provide maps of lines of excision for rectal cancer?. Lancet 357 (2001) 495-496
48. Beets-Tan R.G., Beets G.L., Vliegen R.F., Kessels A.G., Van Boven H., De Bruine A., von Meyenfeldt M.F., Baeten C.G., and van Engelshoven J.M. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 357 (2001) 497-504
49. Sauer R., Becker H., Hohenberger W., Rodel C., Wittekind C., Fietkau R., Martus P., Tschmelitsch J., Hager E., Hess C.F., Karstens J.H., Liersch T., Schmidberger H., Raab R., and German Rectal Cancer Study G. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351 (2004) 1731-1740
50. Rex D., Cummings O., and Ulbright T. Coming to terms with pathologists over colon polyps with cancer or high-grade dysplasia. J Clin Gastroenterol 39 (2005) 1-3
51. Practice parameters Committee of the American College of Gastroenterology, and Bond J.H. Polyp guideline. diagnosis, treatment, and surveillance for patients with colorectal polyps. Am J Gastroenterol 95 (2000) 3053-3063
52. Langevin J.M., and Nivatvongs S. The true incidence of synchronous cancer of the large bowel. A prospective study. Am J Surg 147 (1984) 330-333
53. Pagana T.J., Ledesma E.J., Mittelman A., and Nava H.R. The use of colonoscopy in the study of synchronous colorectal neoplasms. Cancer 53 (1984) 356-359
54. Rex D., Sledge G., Harper P., Ulbright T., Loehrer P., Helper D., Smith J., Wiersema M., Hawes R., and Lehman G. Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests. influence of age, gender, and family history. Am J Gastroenterol 88 (1993) 825-831
55. Lieberman D., Weiss D., Bond J., Ahnen D., Garewal H., and Chejfec G. 380. VACSG. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med 343 (2000) 162-168
56. Imperiale T., Wagner D., Lin C., Larkin G., Rogge J., and Ransohoff D. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 343 (2000) 169-174
57. Imperiale T.F., Ransohoff D.F., Itzkowitz S.H., Turnbull B.A., Ross M.E., and Colorectal Cancer Study G. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 351 (2004) 2704-2714
58. Cali R.L., Pitsch R.M., Thorson A.G., Watson P., Tapia P., Blatchford G.J., and Christensen M.A. Cumulative incidence of metachronous colorectal cancer. Dis Colon Rectum 36 (1993) 388-393
59. National Polyp Study Work Group, Winawer S.J., Stewart E.T., Zauber A.G., Bond J.H., Ansel H., Waye J.D., Hall D., Hamlin J.A., Schapiro M., O'Brien M.J., Sternberg S.S., and Gottlieb L.A. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. N Engl J Med 342 (2000) 1766-1772
60. Rockey D., Paulson E., Favis W., et al. Multicenter prospective comparison of colon imaging tests. (abstr). Gastroenterology 126 (2004) A2004
61. Johnson C.D., Harmsen W.S., Wilson L.A., McCarty R.L., Welch T.J., Ilstrup D.M., and Ahlquist D.A. Prospective blinded evaluation of computed tomographic colonography for screen detection of colorectal polyps. Gastroenterology 125 (2003) 311-319
62. Cotton P.B., Durkalski V.L., Pineau B.C., Palesch Y.Y., Mauldin P.D., Hoffman B., Vining D.J., Small W.C., Affronti J., Rex D.K., et al. Computed tomographic colonography (virtual colonoscopy). A multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. JAMA 291 (2004) 1713-1719
63. Pickhardt P.J., Choi J.R., Hwang I., Butler J.A., Puckett M.L., Hildebrandt H.A., Wong R.K., Nugent P.A., Mysliwiec P.A., and Schindler W.R. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 349 (2003) 2191-2200
64. Finkelstein S., and Bini E.J. Annual fecal occult blood testing can be safely suspended for up to 5 years after a negative colonoscopy in asymptomatic average-risk patients. Gastrointest Endosc 61 (2005) AB250
65. Bampton P.A., Sandford J.J., Cole S.R., Smith A., Marcon J., Cadd B., and Young G.P. Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathology. Gut 54 (2005) 803-806
66. Imperiale T.F., Ransohoff D.F., Itzkowitz S.H., Turnbull B.A., and Ross M.E. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 351 (2004) 2704-2714